✦ LIBER ✦

Tumor microenvironment in head and neck squamous cell carcinomas: Predictive value and clinical relevance of hypoxic markers. A review

✍ Scribed by Ilse J. Hoogsteen; Henri A. M. Marres; Johan Bussink; Albert J. van der Kogel; Johannes H. A. M. Kaanders

Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 340 KB
Volume: 29
Category: Article
ISSN: 1043-3074
DOI: 10.1002/hed.20543

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Background.

Hypoxia and tumor cell proliferation are important factors determining the treatment response of squamous cell carcinomas of the head and neck. Successful approaches have been developed to counteract these resistance mechanisms although usually at the cost of increased short‐ and long‐term side effects. To provide the best attainable quality of life for individual patients and the head and neck cancer patient population as a whole, it is of increasing importance that tools be developed that allow a better selection of patients for these intensified treatments.

Methods.

A literature review was performed with special focus on the predictive value and clinical relevance of endogenous hypoxia‐related markers.

Results.

New methods for qualitative and quantitative assessment of functional microenvironmental parameters such as hypoxia, proliferation, and vasculature have identified several candidate markers for future use in predictive assays. Hypoxia‐related markers include hypoxia inducible factor (HIF)‐1α, carbonic anhydrase IX, glucose transporters, erythropoietin receptor, osteopontin, and others. Although several of these markers and combinations of markers are associated with treatment outcome, their clinical value as predictive factors remains to be established.

Conclusions:

A number of markers and marker profiles have emerged that may have potential as a predictive assay. Validation of these candidate assays requires testing in prospective trials comparing standard treatment against experimental treatments targeting the related microregional constituent. © 2007 Wiley Periodicals, Inc. Head Neck, 2007

📜 SIMILAR VOLUMES

Tumor lymphangiogenesis in head and neck

Tumor lymphangiogenesis in head and neck squamous cell carcinoma : A morphometric study with clinical correlations

✍ Alessandro Franchi; Oreste Gallo; Daniela Massi; Gianna Baroni; Marco Santucci 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 159 KB 👁 1 views

## Abstract ## BACKGROUND Tumor metastasis to regional lymph nodes via the lymphatic system represents the first step of dissemination in head and neck squamous cell carcinoma (HNSCC) and serves as a major prognostic indicator for disease progression and as a guide for therapeutic strategies. In t

Predictive value of cathepsin-D for cerv

Predictive value of cathepsin-D for cervical lymph node metastasis in head and neck squamous cell carcinoma

✍ Regina Gandour-Edwards; Bruce Trock; Paul J. Donald 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 3 views

Background. Prognosis of head and neck squamous cell carcinoma (HNSCC) is strongly associated with cervical lymph node metastasis. Cathepsin-D is a lysosomal protease expressed in all cells. Its role in extracellular matrix degradation is postulated to promote tumor invasion and metastasis. Increase

Molecular markers predict outcome in squ

Molecular markers predict outcome in squamous cell carcinoma of the head and neck after concomitant cisplatin-based chemoradiation

✍ Guido B. van den Broek; Maarten Wildeman; Coen R.N. Rasch; Nicola Armstrong; Ed 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 141 KB 👁 1 views

## Abstract Not all patients with squamous cell carcinomas of the head and neck (HNSCC) benefit from concurrent cisplatin‐based chemoradiation, but reliable predictive markers for outcome after chemoradiation are scarce. We have investigated potential prognostic biomarkers for outcome in a large gr

Staging of head and neck squamous cell c

Staging of head and neck squamous cell carcinoma using the MET oncogene product as marker of tumor cells in lymph node metastases

✍ Giorgio Cortesina; Tiziana Martone; Emanuela Galeazzi; Martina Olivero; Antonell 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 347 KB 👁 3 views

In head and neck squamous cell carcinomas (HNSCC), metastasis to cervical lymph nodes is a major determinant of patient outcome. To detect metastases, we used the MET oncogene as marker, which encodes the receptor for hepatocyte growth factor/scatter factor, mediating epithelial cell motility and in

Investigation of urinary transforming gr

Investigation of urinary transforming growth factor alpha levels as tumor markers in patients with advanced squamous cell carcinoma of the head and neck

✍ Mary Fazekas-May; Dr. James Y. Suen; Yun Chi Yeh; Hsing Wu Yeh; Lynda Beth Milli 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 436 KB 👁 2 views

## Abstract The objective of this study was to determine whether transforming growth factor alpha (TGF alpha) levels could be used as nonspecific tumor markers in patients with advanced squamous cell carcinoma (SCC) of the head and neck. Fourteen patients with epidermoid carcinoma of the head and n

Feasibility of immunocytochemical detect

Feasibility of immunocytochemical detection of tumor markers (XIAP, phosphohistone H1 and p63) in FNA cellblock samples from head and neck squamous cell carcinoma

✍ M. Wu; A. Kafanas; L. Gan; D. S. Kohtz; L. Zhang; E. Genden; D. E. Burstein 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 195 KB